Retrospective analysis of topotecan administered weekly in heavily pretreated recurrent epithelial ovarian carcinoma patients.

被引：0
|
作者：
O'Malley, D [1 ]
Makkenchery, A [1 ]
Tangir, J [1 ]
Kelly, M [1 ]
Azodi, M [1 ]
Chambers, S [1 ]
Schwartz, P [1 ]
Rutherford, T [1 ]
机构：
[1] Yale Univ, Med Ctr, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5079
引用
收藏
页码：468S / 468S
页数：1
相关论文
共 50 条
  • [1] Weekly topotecan in heavily pretreated patients with recurrent epithelial ovarian carcinoma
    O'Malley, DM
    Azodi, M
    Makkenchery, A
    Tangir, J
    McAlpine, J
    Kelly, M
    Schwartz, P
    Rutherford, T
    GYNECOLOGIC ONCOLOGY, 2005, 98 (02) : 242 - 248
  • [2] The use of weekly topotecan in the treatment of heavily pretreated recurrent epithelial ovarian and primary peritoneal cancer: The Kaohsiung Chang Gung experience
    Hu, Ching-Fen
    Ou, Yu-Che
    Fu, Hung-Chun
    Chien, Chan-Chao Chang
    Tsai, Chin-Chou
    Wu, Chen-Hsuan
    Lin, Hao
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2015, 54 (01): : 43 - 47
  • [3] Effectiveness of weekly topotecan in patients with recurrent epithelial ovarian cancer
    Vandenput, I.
    Amant, F.
    Neven, P.
    Berteloot, P.
    Leunen, K.
    Vergote, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (01) : 83 - 87
  • [4] Three-Day Topotecan Schedule in Heavily Pretreated Recurrent Ovarian Cancer Patients
    Calcagno, Marco
    Bellati, Filippo
    Palaia, Innocenza
    Plotti, Francesco
    Basile, Stefano
    Pastore, Maria
    Sansone, Milena
    Arrivi, Cristiana
    Angioli, Roberto
    Panici, Pierluigi Benedetti
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (03) : 455 - 459
  • [5] Weekly single-agent carboplatin in heavily pretreated patients with recurrent ovarian, peritoneal and fallopian tube carcinoma
    Piura, B
    Meirovitz, M
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2005, 26 (04) : 386 - 390
  • [6] Salvage therapy with topotecan in heavily pretreated ovarian cancer patients
    Lubomir Bodnar
    Gabriel Wcislo
    Anna Nasilowska
    Katarzyna Szarlej-Wcislo
    Agnieszka Gasowska-Bodnar
    Marta Smoter
    Cezary Szczylik
    Journal of Cancer Research and Clinical Oncology, 2009, 135
  • [7] Salvage therapy with topotecan in heavily pretreated ovarian cancer patients
    Bodnar, Lubomir
    Wcislo, Gabriel
    Nasilowska, Anna
    Szarlej-Wcislo, Katarzyna
    Gasowska-Bodnar, Agnieszka
    Smoter, Marta
    Szczylik, Cezary
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (06) : 815 - 821
  • [8] Topotecan in heavily pretreated platinum resistant ovarian cancer patients
    Aravantinos, G
    Zafiropoulos, A
    Bafaloukos, D
    Samantas, E
    Janinis, J
    Papakostas, P
    Sikiotis, A
    Kiamouris, C
    Rapsomaniki, T
    Skarlos, DV
    ANNALS OF ONCOLOGY, 1998, 9 : 67 - 67
  • [9] Weekly topotecan in the treatment of recurrent and persistent epithelial ovarian cancer
    Safra, Tamar
    Inbar, Moshe
    Menczer, Joseph
    Grisaro, Dan
    Glezerman, Marek
    Levy, Tally
    ANNALS OF ONCOLOGY, 2004, 15 : 136 - 136
  • [10] Weekly topotecan as a salvage therapy in heavily pre-treated patients with recurrent platinum-resistant epithelial ovarian cancer
    Marinaccio, M.
    De Marino, E.
    Mele, E.
    Catacchio, R.
    Meo, D.
    Iezzoni, C.
    Conversano, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345